SURgical Registry of ENDocarditis EuRope

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Essen

About this trial

This is a prospective, multicentric, european registry of patients with infective endocarditis undergoing cardiac surgery. Patient demographics, clinical data and laboratory values will be collected, as well as treatment outcomes at day 30, day 90 and 1-5 years after the intervention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with infective endocarditis (according to DUKE criteria) undergoing cardiac surgery

Age ≥18 years

Written informed consent

Disqualifiers

Age < 18 years

Missing declaration of consent

Current participation in another interventional trial

Trial population

Patients with infective endocarditis undergoing open heart surgery with cardio-pulmonary bypass

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Cardiac surgery

    Procedure/Surgery

    Patients with infective endocarditis undergoing open heart surgery

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

In-hospital mortality (all cause)

Overall mortality rate in-hospital, at day 30 or during index hospitalization

Time frame
30 days or during index hospitalization
2

Mortality at long-term follow-up

at 1 to 5 years post-surgery

Time frame
1 to 5 years

Secondary outcomes

1

MACCE

Major adverse cardiac and cerebrovascular event rate at day 30 or during index hospitalization. Composite of 1.) Cardiac events: (postoperative myocardial infarction, CPR, LCOS/heart failure, repeat cardiac surgery) and/or cerebrovascular events (postoperative stroke, TIA, intracranial hemorrhage)

Time frame
30 days or during index hospitalization
2

MACCE at long term follow-up

Major adverse cardiac and cerebrovascular event rate at 1 to 5 years post-surgery

Time frame
1 to 5 years
3

Sepsis accociated mortatilty

Sepsis accociated mortatilty at day 30 or during index hospitalization

Time frame
30 days or during index hospitalization
4

Post-operative sepsis

Sepsis at day 30 or during index hospitalization

Time frame
30 days or during index hospitalization

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: